Carrolee Barlow - Feb 22, 2024 Form 4 Insider Report for SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Role
Director
Signature
/s/ Timothy C. Dec, as attorney-in-fact
Stock symbol
SUPN
Transactions as of
Feb 22, 2024
Transactions value $
$0
Form type
4
Date filed
2/26/2024, 05:02 PM
Previous filing
Feb 27, 2023
Next filing
Feb 27, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SUPN Common Stock 13.3K Feb 22, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SUPN Director Stock Option (Right to Buy) Award $0 +8.25K $0.00 8.25K Feb 22, 2024 Common Stock 8.25K $27.94 Direct F1
transaction SUPN Restricted Stock Units Award $0 +5.37K $0.00 5.37K Feb 22, 2024 Common Stock 5.37K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests on February 22, 2025
F2 Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.
F3 These restricted stock units will be settled in common stock upon vesting, which will occur on February 22, 2025.